To view this email as a web page, click here

Today's Rundown

Featured Story

Lilly's COVID antibody combo halted nationwide, dealing huge blow to blockbuster program

With a pair of troubling coronavirus variants on the rise, the U.S. is pausing national distribution of Eli Lilly’s COVID-19 antibody combo of bamlanivimab and etesevimab until further notice.

read more

Top Stories

Roche nabs FDA emergency nod for Actemra in severe COVID-19 despite mixed trial results

Roche’s Actemra may have turned up mixed results in COVID-19 clinical trials, but the FDA thinks the rheumatoid arthritis drug has shown enough benefit in some severe patients to deserve an emergency use authorization.

read more

COVID-19 tracker: World is 'failing' as poor nations go without shots, WHO chief says; Lilly antibody halted in US

The head of the World Health Organization scolded richer nations for vaccinating their entire populations, even those less at-risk, before sending doses to poorer countries. Shipments of Eli Lilly's antibody combo were halted in the U.S. because of variant concerns. And more headlines.

read more

Biden quietly transforms Medicaid safety net

The Biden administration is quietly engineering a series of expansions to Medicaid that may bolster protections for millions of low-income Americans and bring more people into the program.

read more